N/A
Completed N=166
Evaluation of an Incentive-based Intervention to Improve 90-day Adherence in PAP-Naive Patients
Source: ClinicalTrials.gov NCT03851094 ↗Enrolled (actual)
166
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: Mean PAP Usage at 90 Days — 4.67; 4.59 hours
Summary
This is a prospective, randomized, open-label study to evaluate effectiveness of applying financial and social incentives via a smartphone-based app in helping participants achieve adherence to PAP therapy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean PAP Usage at 90 Days |
4.67; 4.59 | — |
| SECONDARY % of Participants That Meet Medicare Compliance Standard |
88; 46 | — |
| SECONDARY Change in ESS Questionnaire Scores |
-1.99; -2.63 | — |
| SECONDARY Change in FOSQ-10 Questionnaire Scores |
0.96; 1.74 | — |
Eligibility Criteria
Inclusion Criteria
- Adult participants (≥ 18 years of age)
- New diagnosis of OSA
- Prescribed CPAP or APAP for treatment of OSA
- Prescribed a ResMed flow generator compatible with AirView
- Owns a smart phone and is willing to download an app on their phone
- Willing and able to give informed consent
- Can read and comprehend written and spoken English
Exclusion Criteria
- Have used PAP therapy in the past
- Have been prescribed bi-level or adaptive servo-ventilation therapy
- Are participating in another app-based research study
- Cannot participate for the full duration of the study (at least 90 days)
- Participants who have a medical history or concurrent illness that the investigator considers sufficiently serious to interfere with the conduct, completion, or results of this study, or constitutes an unacceptable risk to the participant for the duration of the study
Data sourced from ClinicalTrials.gov (NCT03851094). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.